| Study name |
Multicenter, double‐blind, randomized, controlled, parallel study of the therapeutic equivalence of intramuscular and intravenous forms of administration of the drug Cortexin®, 10 mg, produced by GEROPHARM LLC, Russia, in relation to the degree of functional recovery in patients in the acute period of ischemic stroke |
| Methods |
Multicentre, double‐blind, randomised, controlled, parallel study |
| Participants |
974 |
| Interventions |
Cortexin 10 mg, produced by GEROPHARM LLC, lyophilisate solution for intramuscular and intravenous administration, 10 mg, no further details provided |
| Outcomes |
No details provided |
| Starting date |
2 December 2021 |
| Contact information |
Limited Liability Company "GEROPHARM", 191119, St. Petersburg, St. Petersburg, Zvenigorodskaya st., 9, Russia |
| Notes |
End date: 31 December 2029 |
